Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orifarm ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orifarm ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; bensalkoniumklorid hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orifarm ab - mometasonfuroat - kräm - 0,1 % - mometasonfuroat 1 mg aktiv substans

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

glenmark pharmaceuticals s.r.o. - mometasonfuroatmonohydrat; olopatadinhydroklorid - nässpray, suspension - 25 mikrogram/dos + 600 mikrogram/dos - mometasonfuroatmonohydrat 25,86 mikrog aktiv substans; etanol, vattenfri hjälpämne; olopatadinhydroklorid 665 mikrog aktiv substans; bensalkoniumklorid hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - läkemedel mot obstruktiv lungsjukdom, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

schering plough europe - mometasonfuroat - inhalationspulver - 200 mikrogram - mometasonfuroat 200 mikrog aktiv substans; laktos (vattenfri) hjälpämne - mometason

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

schering plough europe - mometasonfuroat - inhalationspulver - 400 mikrogram - mometasonfuroat 400 mikrog aktiv substans; laktos (vattenfri) hjälpämne - mometason